MATTHEW D LINNIK Insider Trading $LJPC LA JOLLA PHARMACEUTICAL CO
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for MATTHEW D LINNIK.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of MATTHEW D LINNIK. MATTHEW D LINNIK is CSO & Exec VP of Research in LA JOLLA PHARMACEUTICAL CO ($LJPC).
MATTHEW D LINNIK in LA JOLLA PHARMACEUTICAL CO
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of MATTHEW D LINNIK: CSO & Exec VP of Research
Holdings: 1,300 shares
Current Value: $25,311
Latest Transaction: Dec 27 2006
$LJPC Market Capitalization: $355.22M
$LJPC Previous Close: $19.47
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of MATTHEW D LINNIK in LA JOLLA PHARMACEUTICAL CO
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 27 2006 | LJPC | LA JOLLA PHARMACEU ... | LINNIK MATTHEW D | CSO & Exec VP of Re ... | Sell | S | 3.03 | 365 | 1,106 | 1,300 | 1.7 K to 1.3 K (-21.92 %) |
| Dec 27 2006 | LJPC | LA JOLLA PHARMACEU ... | LINNIK MATTHEW D | CSO & Exec VP of Re ... | Sell | S | 2.88 | 5,000 | 14,394 | 1,665 | 6.7 K to 1.7 K (-75.02 %) |
| Dec 20 2006 | LJPC | LA JOLLA PHARMACEU ... | LINNIK MATTHEW D | CSO & Exec VP of Re ... | Sell | D | 3.00 | 2,500 | 7,500 | 6,665 | 9.2 K to 6.7 K (-27.28 %) |
| Dec 20 2006 | LJPC | LA JOLLA PHARMACEU ... | LINNIK MATTHEW D | CSO & Exec VP of Re ... | Sell | D | 3.01 | 3,500 | 10,530 | 9,165 | 12.7 K to 9.2 K (-27.64 %) |
| Dec 18 2006 | LJPC | LA JOLLA PHARMACEU ... | LINNIK MATTHEW D | CSO & Exec VP of Re ... | Sell | D | 3.02 | 7,500 | 22,625 | 12,665 | 20.2 K to 12.7 K (-37.19 %) |
| Dec 18 2006 | LJPC | LA JOLLA PHARMACEU ... | LINNIK MATTHEW D | CSO & Exec VP of Re ... | Sell | D | 3.12 | 1,500 | 4,680 | 20,165 | 21.7 K to 20.2 K (-6.92 %) |
| Apr 18 2006 | LJPC | LA JOLLA PHARMACEU ... | LINNIK MATTHEW D | CSO & Exec VP of Re ... | Option Exercise | A | 4.46 | 310,430 | 1,384,518 | 361,027 | |
| Dec 15 2005 | LJPC | LA JOLLA PHARMACEU ... | LINNIK MATTHEW D | CSO & Exec VP of Re ... | Grant | A | 0.00 | 101,827 | 0 | 108,324 | 6.5 K to 108.3 K (+1,567.29 %) |
| Oct 12 2005 | LJPC | LA JOLLA PHARMACEU ... | LINNIK MATTHEW D | CSO & Exec VP of Re ... | Option Exercise | A | 0.00 | 143,000 | 0 | 253,000 | |
| May 20 2005 | LJPC | LA JOLLA PHARMACEU ... | LINNIK MATTHEW D | CSO & Exec VP of Re ... | Option Exercise | A | 0.00 | 37,235 | 0 | 110,000 | |
| Apr 27 2005 | LJPC | LA JOLLA PHARMACEU ... | LINNIK MATTHEW D | CSO & Exec VP of Re ... | Option Exercise | G | 0.00 | 787,169 | 0 | 787,169 | |
| Apr 27 2005 | LJPC | LA JOLLA PHARMACEU ... | LINNIK MATTHEW D | CSO & Exec VP of Re ... | Option Exercise | G | 0.00 | 787,169 | 0 | 72,765 | |
| Apr 27 2005 | LJPC | LA JOLLA PHARMACEU ... | LINNIK MATTHEW D | CSO & Exec VP of Re ... | Option Exercise | A | 0.00 | 72,765 | 0 | 859,934 | |
| Apr 27 2005 | LJPC | LA JOLLA PHARMACEU ... | LINNIK MATTHEW D | CSO & Exec VP of Re ... | Buy | J | 0.60 | 1,133 | 674 | 6,497 | 5.4 K to 6.5 K (+21.12 %) |
| May 25 2004 | LJPC | LA JOLLA PHARMACEU ... | LINNIK MATTHEW D | CSO & Exec VP of Re ... | Option Exercise | A | 2.96 | 122,000 | 361,120 | 122,000 | |
| May 25 2004 | LJPC | LA JOLLA PHARMACEU ... | LINNIK MATTHEW D | CSO & Exec VP of Re ... | Buy | J | 1.48 | 1,025 | 1,516 | 3,815 | 2.8 K to 3.8 K (+36.74 %) |
Page: 1